Protalix BioTherapeutics Management
Management criteria checks 3/4
Protalix BioTherapeutics' CEO is Dror Bashan, appointed in Jun 2019, has a tenure of 4.92 years. total yearly compensation is $1.47M, comprised of 24.5% salary and 75.5% bonuses, including company stock and options. directly owns 3.11% of the company’s shares, worth $2.76M. The average tenure of the management team and the board of directors is 4.8 years and 4.6 years respectively.
Key information
Dror Bashan
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 24.5% |
| CEO tenure | 4.9yrs |
| CEO ownership | 3.1% |
| Management average tenure | 4.8yrs |
| Board average tenure | 4.6yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$8m |
| Sep 30 2023 | n/a | n/a | US$11m |
| Jun 30 2023 | n/a | n/a | US$9m |
| Mar 31 2023 | n/a | n/a | -US$16m |
| Dec 31 2022 | US$1m | US$360k | -US$15m |
| Sep 30 2022 | n/a | n/a | -US$18m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$24m |
| Dec 31 2021 | US$1m | US$374k | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$21m |
| Jun 30 2021 | n/a | n/a | -US$21m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$1m | US$352k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | US$566k | US$175k | -US$18m |
Compensation vs Market: Dror's total compensation ($USD1.47M) is above average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: Dror's compensation has been consistent with company performance over the past year.
CEO
Dror Bashan (56 yo)
4.9yrs
Tenure
US$1,468,296
Compensation
Mr. Dror Bashan has been President, Chief Executive Officer and Director of Protalix BioTherapeutics, Inc. since June 30, 2019. He has experience in the pharmaceutical industry with roles ranging from busi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.9yrs | US$1.47m | 3.11% $ 2.8m | |
| Senior VP | 4.7yrs | US$1.06m | 0.78% $ 689.7k | |
| Senior Vice President of Operations | 6yrs | US$533.27k | 0.28% $ 250.8k | |
| Vice President of Human Resources | 1.8yrs | no data | no data |
4.8yrs
Average Tenure
56yo
Average Age
Experienced Management: PLX's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.9yrs | US$1.47m | 3.11% $ 2.8m | |
| Independent Director | 15.8yrs | US$61.46k | 0.00023% $ 204.0 | |
| Independent Director | 9.5yrs | US$61.46k | 0.24% $ 210.5k | |
| Independent Director | 4.3yrs | US$61.46k | no data | |
| Member of Scientific Advisory Board | 7.9yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.9yrs | US$33.40k | no data | |
| Chairman of Scientific Advisory Board | no data | US$55.00k | no data | |
| Independent Chairman | less than a year | no data | no data | |
| Independent Director | 4.3yrs | US$61.46k | 0.000050% $ 44.4 |
4.6yrs
Average Tenure
70.5yo
Average Age
Experienced Board: PLX's board of directors are considered experienced (4.6 years average tenure).